Home LiteratureArticle Details
PMID: 19637142 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Surface binding inhibitors of the SCF-KIT protein-protein interaction.

Chembiochem : a European journal of chemical biology ·Vol. 10 ·No. 12 ·2009-08-17 ·Pages 1955-8

Margulies D, Opatowsky Y, Fletcher S, Saraogi I, Tsou LK, Saha S, Lax I, Schlessinger J, Hamilton AD

Abstract

暂无摘要

MeSH Terms
Enzyme Inhibitors/chemistry,pharmacology Inhibitory Concentration 50 Ligands Models, Molecular Protein Binding/drug effects Proto-Oncogene Proteins c-kit/chemistry,metabolism Signal Transduction Stem Cell Factor/chemistry,metabolism Surface Properties
Chemicals
Enzyme Inhibitors Ligands Stem Cell Factor Proto-Oncogene Proteins c-kit
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Margulies David
Department of Chemistry, Yale University, New Haven, CT 06520-8107 (USA).
Opatowsky Yarden
Fletcher Steven
Saraogi Ishu
Tsou Lun K
Saha Sourav
Lax Irit
Schlessinger Joseph
Hamilton Andrew D
References (36)
36 references, click to expand
  1. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.
    Science. 1998 Jan 23;279(5350):577-80 PMID: 9438854
  2. Coexpression of the c-kit and stem cell factor genes in breast carcinomas.
    Cell Growth Differ. 1995 Jun;6(6):769-79 PMID: 7545433
  3. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces.
    Nature. 2007 Dec 13;450(7172):1001-9 PMID: 18075579
  4. Disruption of protein-protein interactions using nanoparticles: inhibition of cytochrome c peroxidase.
    Chem Commun (Camb). 2006 Apr 7;(13):1390-2 PMID: 16550276
  5. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.
    Nat Rev Drug Discov. 2004 Apr;3(4):301-17 PMID: 15060526
  6. The biology of stem cell factor and its receptor C-kit.
    Int J Biochem Cell Biol. 1999 Oct;31(10):1037-51 PMID: 10582338
  7. Strategies for targeting protein-protein interactions with synthetic agents.
    Angew Chem Int Ed Engl. 2005 Jul 4;44(27):4130-63 PMID: 15954154
  8. Benzoylurea oligomers: synthetic foldamers that mimic extended alpha helices.
    Angew Chem Int Ed Engl. 2007;46(45):8614-7 PMID: 17918270
  9. Porphyrin analogues as novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding that inhibit endothelial cell proliferation, tumor progression, and metastasis.
    Cancer Res. 2000 Jun 1;60(11):2973-80 PMID: 10850445
  10. Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides.
    Angew Chem Int Ed Engl. 2007;46(24):4471-3 PMID: 17487924
  11. Lack of KIT or FMS internal tandem duplications but co-expression with ligands in AML.
    Leuk Res. 2004 Feb;28(2):121-6 PMID: 14654075
  12. Facial control of nanoparticle binding to cytochrome C.
    J Am Chem Soc. 2007 Mar 14;129(10):2732-3 PMID: 17309259
  13. Protein surface recognition by synthetic receptors based on a tetraphenylporphyrin scaffold.
    Org Lett. 2000 Jun 15;2(12):1721-3 PMID: 10880210
  14. A journey in structure-based drug discovery: from designed peptides to protein surface topomimetics as antibiotic and antiangiogenic agents.
    Acc Chem Res. 2007 Oct;40(10):1057-65 PMID: 17661438
  15. beta-Peptides as inhibitors of protein-protein interactions.
    Bioorg Med Chem. 2005 Jan 3;13(1):11-6 PMID: 15582447
  16. Foldamers as versatile frameworks for the design and evolution of function.
    Nat Chem Biol. 2007 May;3(5):252-62 PMID: 17438550
  17. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
    J Am Chem Soc. 2005 Jul 27;127(29):10191-6 PMID: 16028929
  18. Design of GFB-111, a platelet-derived growth factor binding molecule with antiangiogenic and anticancer activity against human tumors in mice.
    Nat Biotechnol. 2000 Oct;18(10):1065-70 PMID: 11017044
  19. Protein surface recognition by rational design: nanomolar ligands for potassium channels.
    J Am Chem Soc. 2003 Oct 22;125(42):12668-9 PMID: 14558789
  20. Development trends for monoclonal antibody cancer therapeutics.
    Nat Rev Drug Discov. 2007 May;6(5):349-56 PMID: 17431406
  21. Controlling curvature in a family of oligoamide alpha-helix mimetics.
    Angew Chem Int Ed Engl. 2008;47(50):9691-4 PMID: 18989875
  22. Kit receptor dimerization is driven by bivalent binding of stem cell factor.
    J Biol Chem. 1997 Mar 7;272(10):6311-7 PMID: 9045650
  23. Synthetic non-peptide mimetics of alpha-helices.
    Chem Soc Rev. 2007 Feb;36(2):326-34 PMID: 17264933
  24. Small-molecule kinase-inhibitor target assessment.
    Chembiochem. 2005 Mar;6(3):523-6 PMID: 15696508
  25. Foldamers with heterogeneous backbones.
    Acc Chem Res. 2008 Oct;41(10):1399-408 PMID: 18590282
  26. Modulation of protein-protein interactions by synthetic receptors: design of molecules that disrupt serine protease-proteinaceous inhibitor interaction.
    Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5105-9 PMID: 11959960
  27. Toward proteomimetics: terphenyl derivatives as structural and functional mimics of extended regions of an alpha-helix.
    J Am Chem Soc. 2001 Jun 6;123(22):5382-3 PMID: 11457415
  28. Catalytic unfolding and proteolysis of cytochrome C induced by synthetic binding agents.
    J Am Chem Soc. 2004 Oct 13;126(40):12833-42 PMID: 15469279
  29. Beyond Herceptin and Gleevec.
    Curr Opin Chem Biol. 2003 Aug;7(4):490-5 PMID: 12941424
  30. Familial gastrointestinal stromal tumours with germline mutation of the KIT gene.
    Nat Genet. 1998 Aug;19(4):323-4 PMID: 9697690
  31. Structure-activity studies on a library of potent calix[4]arene-based PDGF antagonists that inhibit PDGF-stimulated PDGFR tyrosine phosphorylation.
    Org Biomol Chem. 2006 Jun 21;4(12):2376-86 PMID: 16763682
  32. Molecular characterization of PDGFR-alpha/PDGF-A and c-KIT/SCF in gliosarcomas.
    Cell Oncol. 2005;27(5-6):319-26 PMID: 16373964
  33. Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor.
    Cell. 2007 Jul 27;130(2):323-34 PMID: 17662946
  34. Terphenyl-based helical mimetics that disrupt the p53/HDM2 interaction.
    Angew Chem Int Ed Engl. 2005 Apr 29;44(18):2704-2707 PMID: 15765497
  35. Directed denaturation: room temperature and stoichiometric unfolding of cytochrome C by a metalloporphyrin dimer.
    J Am Chem Soc. 2003 Apr 16;125(15):4420-1 PMID: 12683802
  36. Targeting protein-protein interactions by rational design: mimicry of protein surfaces.
    J R Soc Interface. 2006 Apr 22;3(7):215-33 PMID: 16849232
Article Info
Journal
Chembiochem : a European journal of chemical biology
Abbr.
Chembiochem
ISSN
1439-7633
DOI
10.1002/cbic.200900079
Published
2009-08-17
Pages
1955-8
Language
English
Region
Germany
NLM ID
100937360
PMCID
PMC2805069
Subset
IM
Grants
NIAMS NIH HHS · P50-AR054086 · United States
NIAMS NIH HHS · R01 AR051886 · United States
NIAMS NIH HHS · R01 AR051448 · United States
NIGMS NIH HHS · R01 GM035208 · United States
NIGMS NIH HHS · R01 GM035208-19S1 · United States
NIGMS NIH HHS · GM35208 · United States
NIAMS NIH HHS · R01-AR051448 · United States
NIAMS NIH HHS · P50 AR054086 · United States
NIAMS NIH HHS · R01-AR051886 · United States
External Links
PubMed source DOI: 10.1002/cbic.200900079 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2